Product Description: Exbivirumab is an anti-HBV mAb. Exbivirumab enhances the antiviral activity of hepatitis B immunoglobulin (HBIG)[1].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]Shouval D, et al. ANTI-VIRAL EFFECTS, PHARMACOKINETICS AND SAFETY OF TWO HUMAN MONOCLONAL ANTI-HBS (LIBIVIRUMAB/EXBIVIRUMAB) VERSUS HEPATITIS B IMMUNE GLOBULIN (HBIG) IN HEPATITS B VIRUS (HBV) IN LIVER TRANSPLANT (LT) RECIPIENTS: 22[J]. Hepatology, 2006, 44: 196A.
CAS Number: 569658-80-6
Molecular Weight: N/A
Compound Purity: 97.04
Research Area: Infection
Solubility: 10 mM in DMSO
Target: HBV